Zevra at Citizens Life Sciences: Strategic Growth and Expansion

Entity Intersection Graph

No entity connections available yet for this article.

}

Original Source

              On Wednesday, 11 March 2026, Zevra Therapeutics (NASDAQ:ZVRA) presented at The Citizens Life Sciences Conference 2026, showcasing its strategic focus on expanding its presence in the rare disease market. The company highlighted its recent financial successes and outlined plans for future growth, while also addressing challenges in geographic expansion and clinical development.
            

Read full article at source